Element’s acquisition of Impact Analytical expands their life sciences footprint in North America.
Element Material Technology announced on Sept. 2, 2021, that it has acquired Impact Analytical. This move is the latest in a series of acquisitions made by Element to expand their life sciences footprint in North America, according to a company press release.
Based in Midland, Michigan, Impact operates in the pharmaceutical, medical device, consumer product, specialty chemicals, and most recently bio-analytics segments. In particular, the company specializes in extractables and leachables.
Element’s acquisition of Impact will add various testing services to their pharmaceutical, medical device, environmental, and food segments. This is intended to complement the life science capabilities the company added with the acquisitions of ALG and Avomeen in the last twelve months, according to the press release.
“As our eighth acquisition this year and our fourth in the life sciences market, we are pleased to welcome Impact Analytical to Element,” said Rick Sluiters, executive vice-president of Americas at Element, in the press release. “With ALG and Avomeen in America and the recent announcement of our acquisition of Arch Sciences Group in Europe, Element has significantly strengthened its position in the life sciences sector.
Source: Element
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.